Abstract
India is the regional leader in research and development (R&D) in agricultural biotechnology (agri‐biotech) in South Asia. Commercialization of Bacillus thuringiensis (Bt) cotton—the first and only commercial genetically engineered (GE) crop in India—in 2002 was preceded by illegal cultivation and diffusion of unapproved cultivars, raising serious questions of the state's regulatory capacity. Bt eggplant, the first GE food crop to get approval for environmental release in 2009, has not yet been commercialized. An indefinite moratorium on its commercialization was imposed by the Minister of Environment and Forests in 2010. We examine the regulatory framework in India and use the cases of Bt cotton and Bt eggplant regulation to examine the types and sources of nonmarket failures associated with the regulatory policy. We also analyze the demonstrated and likely effects of regulatory uncertainty on social welfare and development of the agri‐biotech industry. We adopt implementation analysis to suggest policy options worth considering to address the nonmarket failures of regulatory policy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Canadian Journal of Agricultural Economics/Revue canadienne d'agroeconomie
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.